Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Moxifloxacin (Medsurge)
Active Ingredient:	Moxifloxacin hydrochloride 436.34mg equivalent to moxifloxacin 400mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Medsurge Pharma Limited
Manufacturer:	Micro Labs Limited, Hosur, India

*Product:*	Moxifloxacin (Medicianz)
Active Ingredient:	Moxifloxacin hydrochloride 436.34mg equivalent to moxifloxacin 400mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Medsurge Pharma Limited
Manufacturer:	Micro Labs Limited, Hosur, India

*Product:*	Moximed
Active Ingredient:	Moxifloxacin hydrochloride 436.34mg equivalent to moxifloxacin 400mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Medsurge Pharma Limited
Manufacturer:	Micro Labs Limited, Hosur, India

Dated this 7th day of July 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule